Abstract 2168: Efficient Detection of Atrial Fibrillation and Congestive Heart Failure in Single-Lead Devices

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Randall Moorman ◽  
Yuping Xiao ◽  
Douglas Lake

Patients receiving primary prevention single lead ICDs are at risk for atrial fibrillation (AF) and congestive heart failure (CHF). No such device reports AF burden, and only a single CHF measure, trans-thoracic impedance, is available. Entropy measures that count the number of matching RR intervals have promise, as AF is random (high entropy) and CHF is often marked by reduced heart rate variability (RR intervals with many matches) and ectopic beats (few matches). We designed entropy-based measures to detect AF (high entropy) and CHF (mixture of RR intervals with many and with few matches). For real-world implementation, we used only 12 RR intervals, and calculated the result every 30 minutes in 24-hour Holter monitor records from the MIT-BIH databases. The Figure shows distinction among AF, NSR and CHF records using HR and S.D. (panel A) or the new entropy-based measures. Panel A shows poor diagnostic performance of conventional measures. In Panel B, the y-axis, COSEn, is the coefficient of sample entropy. The AF records all have higher values, and the ROC area is 1.00. The x-axis is a measure of template match counts. It distinguishes between normals and CHF patients with ROC area 0.92. With only 12 RR intervals every 30 minutes, entropy calculations allow for efficient detection of AF and CHF. We propose that single lead devices can be employed as monitors in the primary prevention population, where risk of AF and CHF is high.

2020 ◽  
Vol 9 (8) ◽  
pp. 931-938 ◽  
Author(s):  
Mattias Skielta ◽  
Lars Söderström ◽  
Solbritt Rantapää-Dahlqvist ◽  
Solveig W Jonsson ◽  
Thomas Mooe

Aims: Rheumatoid arthritis may influence the outcome after an acute myocardial infarction. We aimed to compare trends in one-year mortality, co-morbidities and treatments after a first acute myocardial infarction in patients with rheumatoid arthritis versus non-rheumatoid arthritis patients during 1998–2013. Furthermore, we wanted to identify characteristics associated with mortality. Methods and results: Data for 245,377 patients with a first acute myocardial infarction were drawn from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admissions for 1998–2013. In total, 4268 patients were diagnosed with rheumatoid arthritis. Kaplan-Meier analysis was used to study mortality trends over time and multivariable Cox regression analysis was used to identify variables associated with mortality. The one-year mortality in rheumatoid arthritis patients was initially lower compared to non-rheumatoid arthritis patients (14.7% versus 19.7%) but thereafter increased above that in non-rheumatoid arthritis patients (17.1% versus 13.5%). In rheumatoid arthritis patients the mean age at admission and the prevalence of atrial fibrillation increased over time. Congestive heart failure decreased more in non-rheumatoid arthritis than in rheumatoid arthritis patients. Congestive heart failure, atrial fibrillation, kidney failure, rheumatoid arthritis, prior diabetes mellitus and hypertension were associated with significantly higher one-year mortality during the study period 1998–2013. Conclusions: The decrease in one-year mortality after acute myocardial infarction in non-rheumatoid arthritis patients was not applicable to rheumatoid arthritis patients. This could partly be explained by an increased age at acute myocardial infarction onset and unfavourable trends with increased atrial fibrillation and congestive heart failure in rheumatoid arthritis. Rheumatoid arthritis per se was associated with a significantly worse prognosis.


2004 ◽  
Vol 10 (4) ◽  
pp. S110
Author(s):  
Lynn G. Tarkington ◽  
Salvatore L. Battaglia ◽  
April W. Simon ◽  
Steven D. Culler ◽  
Edmund R. Becker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document